News Listing

AMSBIO has announced new additions to its portfolio of tools for COVID-19 research - two monoclonal antibodies that recognize the Spike RBD (B.1.1.529, Omicron Variant) protein and neutralizes its interaction with ACE2. The human ACE2 receptor is found on the surface of type I and II pneumocytes, endothelial cells, and ciliated bronchial epithelial cells. Research has shown that ACE2 mediates ...

Oxford, UK, and Boston, MA - Samsara Therapeutics Inc. (Samsara), a discovery-stage biotech with a world-leading screening platform for inducers of autophagy and a growing pipeline of small molecule neurodegeneration and rare disease therapeutics, today announced the formation of its scientific advisory board (SAB) with the appointment of four distinguished leaders in the areas of ...

Greater Manchester-based Seda Pharmaceutical Development Services reveals expansion plans following acquisition of new property. The firm is on track to double its staff and turnover in the next few years in line with huge growth in demand for its services. Santander UK provides £2m funding to support the award-winning business’ growth plans

AMSBIO has expanded its range of custom gene editing services to complement its extensive portfolio of off-the-shelf CRISPR/Cas9 products.

A powerful technology, widely used in genome science, Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR) / Cas9 is a simple and efficient editing tool which allows for specific genome disruption and replacement facilitating the manipulation ...

This month marks a key milestone at The EpiCentre in Haverhill with the announcement that CodiKoat, one of its first life sciences occupiers is expanding, further boosting the centre’s reputation as a credible innovation space within East Anglia.

Milton Park is a dynamic science and technology park in Oxfordshire and one of the largest in Europe. It is a collaborative working environment and a welcoming community that fuels innovation and sustainable growth for more than 250 businesses and 9,000 people.

AMSBIO has announced a new range of kits, media and reagents to assist in the development of cultured meat products - an exciting new area of food technology. 

Cultured meat, also known as synthetic, artificial or in-vitro meat, is created by harvesting animal cells that are then placed in a bioreactor and fed with nutrients to help tissue growth. The driving force behind this rapidly expanding ...

GenScript ProBio announced today the opening of China's largest commercial GMP plasmid manufacturing facility during a ceremony at the site in Zhenjiang, Jiangsu Province. The 6,400-square-meter manufacturing plant enables GenScript ProBio to offer global customers a one-stop service for plasmids - from preclinical study (IIT), to investigational new drug (IND) filing, to clinical trial and ...

Oxford, UK, December 3 2021 - Oxfordshire companies which are progressing valuable innovations can apply now for The Oxford Science Park Innovation Award, one of 2022's Oxfordshire Business Awards (OXBA). The Oxford Science Park, one of the UK's leading parks for science and technology companies, is pleased to continue sponsoring this important recognition of innovation as the Awards resume. Under ...

Global provider of human and animal biospecimens - AMSBIO offers a custom procurement service enabling researchers to source specific biofluid and tissue samples which are not already available in their extensive biorepository.

To support increasingly complex research, AMSBIO aims to provide a full range of blood-based products, including whole blood, serum, plasma, blood and peripheral blood ...